48 related articles for article (PubMed ID: 21475997)
1. Association between rs3803662 polymorphism of trinucleotide repeat containing 9 gene and breast cancer risk.
Chen W
Breast Cancer Res Treat; 2011 Aug; 129(1):285-6. PubMed ID: 21475997
[No Abstract] [Full Text] [Related]
2. Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects.
Chen MB; Wu XY; Shen W; Wei MX; Li C; Cai B; Tao GQ; Lu PH
Breast Cancer Res Treat; 2011 Feb; 126(1):177-83. PubMed ID: 20703937
[TBL] [Abstract][Full Text] [Related]
3. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
[TBL] [Abstract][Full Text] [Related]
4. No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis.
Qi XL; Yao J; Zhang Y
BMC Med Genet; 2017 Oct; 18(1):123. PubMed ID: 29084518
[TBL] [Abstract][Full Text] [Related]
5. Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population.
He Y; Liu H; Chen Q; Sun X; Liu C; Shao Y
Tumour Biol; 2016 Jul; 37(7):9739-44. PubMed ID: 26803517
[TBL] [Abstract][Full Text] [Related]
6. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome and breast cancer subtypes: a Mendelian randomization study.
Zhu T; Cui J; Goodarzi MO
Am J Obstet Gynecol; 2021 Jul; 225(1):99-101. PubMed ID: 33771497
[No Abstract] [Full Text] [Related]
8. The progesterone receptor Val660-->Leu polymorphism and breast cancer risk.
De Vivo I; Hankinson SE; Colditz GA; Hunter DJ
Breast Cancer Res; 2004; 6(6):R636-9. PubMed ID: 15535845
[TBL] [Abstract][Full Text] [Related]
9. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
[TBL] [Abstract][Full Text] [Related]
10. No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.
Feigelson HS; Rodriguez C; Jacobs EJ; Diver WR; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1084-5. PubMed ID: 15184270
[No Abstract] [Full Text] [Related]
11. No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.
Manolitsas TP; Englefield P; Eccles DM; Campbell IG
Br J Cancer; 1997; 75(9):1398-9. PubMed ID: 9155067
[No Abstract] [Full Text] [Related]
12. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
[TBL] [Abstract][Full Text] [Related]
13. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
14. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
[TBL] [Abstract][Full Text] [Related]
16. Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women.
Ho HP; Westberg L; Annerbrink K; Olsson M; Melke J; Nilsson S; Baghaei F; Rosmond R; Holm G; Björntorp P; Andersch S; Allgulander C; Eriksson E
Psychoneuroendocrinology; 2004 Oct; 29(9):1138-41. PubMed ID: 15219637
[TBL] [Abstract][Full Text] [Related]
17. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
18. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study.
Fernández LP; Milne RL; Barroso E; Cuadros M; Arias JI; Ruibal A; Benítez J; Ribas G
Int J Cancer; 2006 Jul; 119(2):467-71. PubMed ID: 16477637
[TBL] [Abstract][Full Text] [Related]
20. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
